2-({5-[2-(4-methylphenyl)quinolin-4-yl]-4-phenyl-4H-1,2,4-triazol-3-yl}sulfanyl)acetic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-({5-[2-(4-methylphenyl)quinolin-4-yl]-4-phenyl-4H-1,2,4-triazol-3-yl}sulfanyl)acetic acid
• 英文别名: 2-[[5-[2-(4-methylphenyl)quinolin-4-yl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]acetic acid
• 化学式: C₂₆H₂₀N₄O₂S
• mdl: MFCD05261232
• 分子量: 452.5
• InChiKey: KQWYIOKUZFDXCP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.5
• 重原子数：
  33
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.076
• 拓扑面积：
  106
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE
  申请人：Mount Sinai School Of Medicine Of New York University

  公开号：EP2413696A1

  公开（公告）日：2012-02-08
• [EN] COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE<br/>[FR] COMPOSITIONS POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
  申请人：SINAI SCHOOL MEDICINE

  公开号：WO2010114636A1

  公开（公告）日：2010-10-07

  The present invention includes Aβ-reducing and/or Aβ-anti-aggregation compounds and their uses in pharmaceutical compositions. The present invention further includes methods of formulating pharmaceutical compositions and methods of administering the compositions for treatment of Alzheimer's disease.